Loading...
Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax(®)) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules
Disease protection provided by herpes zoster (HZ) vaccination tends to reduce as age increases. This study was designed to ascertain whether a second dose of the HZ vaccine, Zostavax(®), would increase varicella zoster virus (VZV)-specific immune response among individuals aged ≥ 70 y. Individuals a...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3903905/ https://ncbi.nlm.nih.gov/pubmed/23319176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.23412 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|